These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16024799)

  • 1. ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.
    Pedeux R; Sengupta S; Shen JC; Demidov ON; Saito S; Onogi H; Kumamoto K; Wincovitch S; Garfield SH; McMenamin M; Nagashima M; Grossman SR; Appella E; Harris CC
    Mol Cell Biol; 2005 Aug; 25(15):6639-48. PubMed ID: 16024799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sumoylation of ING2 regulates the transcription mediated by Sin3A.
    Ythier D; Larrieu D; Binet R; Binda O; Brambilla C; Gazzeri S; Pedeux R
    Oncogene; 2010 Nov; 29(44):5946-56. PubMed ID: 20676127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine zipper-like domain is required for tumor suppressor ING2-mediated nucleotide excision repair and apoptosis.
    Wang Y; Wang J; Li G
    FEBS Lett; 2006 Jul; 580(16):3787-93. PubMed ID: 16782091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma.
    Ythier D; Brambilla E; Binet R; Nissou D; Vesin A; de Fraipont F; Moro-Sibilot D; Lantuejoul S; Brambilla C; Gazzeri S; Pedeux R
    Lung Cancer; 2010 Aug; 69(2):180-6. PubMed ID: 19962781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
    Pearson M; Carbone R; Sebastiani C; Cioce M; Fagioli M; Saito S; Higashimoto Y; Appella E; Minucci S; Pandolfi PP; Pelicci PG
    Nature; 2000 Jul; 406(6792):207-10. PubMed ID: 10910364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.
    Kumamoto K; Spillare EA; Fujita K; Horikawa I; Yamashita T; Appella E; Nagashima M; Takenoshita S; Yokota J; Harris CC
    Cancer Res; 2008 May; 68(9):3193-203. PubMed ID: 18451145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.
    Ito A; Lai CH; Zhao X; Saito S; Hamilton MH; Appella E; Yao TP
    EMBO J; 2001 Mar; 20(6):1331-40. PubMed ID: 11250899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMR/c-Abl-dependent activation of ING2/p73alpha signaling regulates the cell death response to N-methyl-N'-nitro-N-nitrosoguanidine.
    Sun G; Jin S; Baskaran R
    Exp Cell Res; 2009 Nov; 315(18):3163-75. PubMed ID: 19766113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiles of p53 and p66shc during oxidative stress-induced senescence in fetal bovine fibroblasts.
    Favetta LA; Robert C; King WA; Betts DH
    Exp Cell Res; 2004 Sep; 299(1):36-48. PubMed ID: 15302571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 targets simian virus 40 large T antigen for acetylation by CBP.
    Poulin DL; Kung AL; DeCaprio JA
    J Virol; 2004 Aug; 78(15):8245-53. PubMed ID: 15254196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.
    Nagashima M; Shiseki M; Miura K; Hagiwara K; Linke SP; Pedeux R; Wang XW; Yokota J; Riabowol K; Harris CC
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9671-6. PubMed ID: 11481424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of growth 2 regulates the high glucose-induced cell cycle arrest and epithelial-to-mesenchymal transition in renal proximal tubular cells.
    Ma Y; Yan R; Wan Q; Lv B; Yang Y; Lv T; Xin W
    J Physiol Biochem; 2020 Aug; 76(3):373-382. PubMed ID: 32424454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase.
    Vaziri H; West MD; Allsopp RC; Davison TS; Wu YS; Arrowsmith CH; Poirier GG; Benchimol S
    EMBO J; 1997 Oct; 16(19):6018-33. PubMed ID: 9312059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence.
    Miyajima C; Kawarada Y; Inoue Y; Suzuki C; Mitamura K; Morishita D; Ohoka N; Imamura T; Hayashi H
    Cells; 2020 Jan; 9(1):. PubMed ID: 31936650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of p53 serine 15 increases interaction with CBP.
    Lambert PF; Kashanchi F; Radonovich MF; Shiekhattar R; Brady JN
    J Biol Chem; 1998 Dec; 273(49):33048-53. PubMed ID: 9830059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ING2 controls the G1 to S-phase transition by regulating p21 expression.
    Larrieu D; Ythier D; Brambilla C; Pedeux R
    Cell Cycle; 2010 Oct; 9(19):3984-90. PubMed ID: 20890119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomas.
    Saito M; Kumamoto K; Robles AI; Horikawa I; Furusato B; Okamura S; Goto A; Yamashita T; Nagashima M; Lee TL; Baxendale VJ; Rennert OM; Takenoshita S; Yokota J; Sesterhenn IA; Trivers GE; Hussain SP; Harris CC
    PLoS One; 2010 Nov; 5(11):e15541. PubMed ID: 21124965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.